1. Home
  2. RAC vs RNAC Comparison

RAC vs RNAC Comparison

Compare RAC & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAC
  • RNAC
  • Stock Information
  • Founded
  • RAC 2024
  • RNAC 2007
  • Country
  • RAC United States
  • RNAC United States
  • Employees
  • RAC N/A
  • RNAC N/A
  • Industry
  • RAC
  • RNAC Biotechnology: Pharmaceutical Preparations
  • Sector
  • RAC
  • RNAC Health Care
  • Exchange
  • RAC Nasdaq
  • RNAC Nasdaq
  • Market Cap
  • RAC 302.3M
  • RNAC 316.1M
  • IPO Year
  • RAC 2025
  • RNAC 2016
  • Fundamental
  • Price
  • RAC $10.30
  • RNAC $11.23
  • Analyst Decision
  • RAC
  • RNAC Strong Buy
  • Analyst Count
  • RAC 0
  • RNAC 4
  • Target Price
  • RAC N/A
  • RNAC $40.00
  • AVG Volume (30 Days)
  • RAC 115.0
  • RNAC 55.2K
  • Earning Date
  • RAC 01-01-0001
  • RNAC 08-07-2025
  • Dividend Yield
  • RAC N/A
  • RNAC N/A
  • EPS Growth
  • RAC N/A
  • RNAC N/A
  • EPS
  • RAC N/A
  • RNAC N/A
  • Revenue
  • RAC N/A
  • RNAC $1,026,000.00
  • Revenue This Year
  • RAC N/A
  • RNAC N/A
  • Revenue Next Year
  • RAC N/A
  • RNAC N/A
  • P/E Ratio
  • RAC N/A
  • RNAC N/A
  • Revenue Growth
  • RAC N/A
  • RNAC N/A
  • 52 Week Low
  • RAC $10.00
  • RNAC $8.46
  • 52 Week High
  • RAC $10.70
  • RNAC $26.50
  • Technical
  • Relative Strength Index (RSI)
  • RAC N/A
  • RNAC 45.84
  • Support Level
  • RAC N/A
  • RNAC $10.50
  • Resistance Level
  • RAC N/A
  • RNAC $11.80
  • Average True Range (ATR)
  • RAC 0.00
  • RNAC 0.74
  • MACD
  • RAC 0.00
  • RNAC -0.07
  • Stochastic Oscillator
  • RAC 0.00
  • RNAC 45.08

About RAC Rithm Acquisition Corp. Class A Ordinary Shares

Rithm Acquisition Corp is a blank check company.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Share on Social Networks: